Assistant Professor of Pediatrics; Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine
Pediatric Hematology & Oncology
Dr. Sarah K. Tasian, MD
|
|
Give Review
Sarah Tasian practices Pediatric Hematology & Oncology. She graduated from Baylor College of Medicine. She over the years received 2 awards: "Alpha Omega Alpha" and "Phi Beta Kappa". Doctor Sarah K. Tasian, MD is also a published doctor. She has 21 paper published. The most recent paper is: Mixed Phenotype Acute Leukemia with Low Hypodiploidy in a Pediatric Patient.
Publications
- Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies.
- Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein.
- Histology of Testicular Biopsies Obtained for Experimental Fertility Preservation Protocol in Boys with Cancer.
- Childhood acute lymphoblastic Leukemia: Integrating genomics into therapy.
- A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, Leukemias, or myeloproliferative neoplasms: A Children's Oncology Group pha...
- Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic Leukemia.
- Targetable kinase-activating lesions in Ph-like acute lymphoblastic Leukemia.
- Efficacy against human acute Myeloid leukemia and myeloablation of normal hematopoiesis in a mouse model using chimeric antigen receptor-modified T cells.
- Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic Leukemia.
- Induction mortality and resource utilization in children treated for acute Myeloid leukemia at free-standing pediatric hospitals in the United States.
- Labial ecthyma gangrenosum in an immunocompromised infant with Leukemia: heightening awareness for the urologist.
- Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic Leukemia.
- Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic Leukemia.
- Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic Leukemia: a Children's Oncology Group study.
- Development of Anaplastic Wilms Tumor and Subsequent Relapse in a Child With Diaphanospondylodysostosis.
- JAK mutations in high-risk childhood acute lymphoblastic Leukemia.
- Influenza-associated morbidity in children with Cancer.
- Mixed Phenotype Acute Leukemia with Low Hypodiploidy in a Pediatric Patient.
- Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia.
- Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches.
Schools
Baylor University
Conditions Treated
- Anemia
- Chronic Myeloid Leukemia (CML)
- Deep Vein Thrombosis (DVT)
- Lymphoma
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Alpha Omega Alpha
- Phi Beta Kappa
Education
-
UCSF -
University of Washington -
Baylor College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Sheila Thampi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anuradha Banerjee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur R. Ablin, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michelle L. Hermiston, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Robert E. Goldsby, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mignon L. Loh, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Christopher C. Dvorak, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|